Category "Okategoriserade"

In its last Quarter ISAB reported a 722% increase in revenues compared to the same time last year. How will it keep up the momentum? CEO Manoush Masarrat…

Will Coronavirus have any long-term impact on ISAB? Is ISAB currently carrying out any Contract Research on Coronavirus? Will there be a ’new normal’ in the inhalation research…

Inhalation Sciences recently shipped two newly commercialized DissolvIt®  units to two customers—in just one week. What are the new and optimized features in this final market version that help…

On 16th September Manoush Masarrat stepped up as new CEO of Inhalation Sciences. With 15 years’ Medtech leadership experience and 10 months as an ISAB Board member, how…

ISAB’s new nebulizer feature delivers the stability, precision and control of a dry powder aerosol—from a liquid solution. Developed by popular demand, four nebulizer modules have already been…

From Austria to Sweden to California to the UK: October has been an intensive month for PreciseInhale®, ISAB’s flagship product. It has been spotlighted by senior ISAB clients…

From Austria to Sweden to California to the UK: October has been an intensive month for PreciseInhale®, ISAB’s flagship product. It has been spotlighted by senior ISAB clients…

ISAB is co-sponsoring a Special Summit “How to succeed with the FDA”, headlined by US regulatory pharma expert Dr Ann Rose, CEO of ViCRO. ISAB Chairman Fredrik Sjövall…

“Pathaway speak our language. Their network and expertise within the UK’s IVD (in vitro diagnostic) market is outstanding”, on June 5 ISAB CEO Lena Heffler met with representatives…

“Pathaway speak our language. Their network and expertise within the UK’s IVD (in vitro diagnostic) market is outstanding”, on June 5 ISAB CEO Lena Heffler met with representatives…